Eltanolone

DB12308

small molecule investigational

Deskripsi

Eltanolone is under investigation in clinical trial NCT02603926 (Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone).

Struktur Molekul 2D

Berat 318.501
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

662 Data
Buprenorphine Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Eltanolone.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Eltanolone.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Eltanolone.
Hydrocodone Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Eltanolone.
Magnesium sulfate The therapeutic efficacy of Eltanolone can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Eltanolone may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Eltanolone.
Mirtazapine Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Eltanolone.
Orphenadrine Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Eltanolone.
Pramipexole Eltanolone may increase the sedative activities of Pramipexole.
Ropinirole Eltanolone may increase the sedative activities of Ropinirole.
Rotigotine Eltanolone may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Eltanolone.
Sodium oxybate Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Suvorexant Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Eltanolone.
Thalidomide Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Eltanolone.
Ethanol Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Azelastine Eltanolone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Brimonidine Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Eltanolone.
Fluvoxamine The risk or severity of adverse effects can be increased when Eltanolone is combined with Fluvoxamine.
Citalopram The risk or severity of adverse effects can be increased when Eltanolone is combined with Citalopram.
Duloxetine The risk or severity of adverse effects can be increased when Eltanolone is combined with Duloxetine.
Trazodone The risk or severity of adverse effects can be increased when Eltanolone is combined with Trazodone.
Paroxetine The risk or severity of adverse effects can be increased when Eltanolone is combined with Paroxetine.
Sertraline The risk or severity of adverse effects can be increased when Eltanolone is combined with Sertraline.
Sibutramine The risk or severity of adverse effects can be increased when Eltanolone is combined with Sibutramine.
Nefazodone The risk or severity of adverse effects can be increased when Eltanolone is combined with Nefazodone.
Escitalopram The risk or severity of adverse effects can be increased when Eltanolone is combined with Escitalopram.
Zimelidine The risk or severity of adverse effects can be increased when Eltanolone is combined with Zimelidine.
Dapoxetine The risk or severity of adverse effects can be increased when Eltanolone is combined with Dapoxetine.
Milnacipran The risk or severity of adverse effects can be increased when Eltanolone is combined with Milnacipran.
Desvenlafaxine The risk or severity of adverse effects can be increased when Eltanolone is combined with Desvenlafaxine.
Seproxetine The risk or severity of adverse effects can be increased when Eltanolone is combined with Seproxetine.
Indalpine The risk or severity of adverse effects can be increased when Eltanolone is combined with Indalpine.
Ritanserin The risk or severity of adverse effects can be increased when Eltanolone is combined with Ritanserin.
Alaproclate The risk or severity of adverse effects can be increased when Eltanolone is combined with Alaproclate.
Amitriptyline The risk or severity of CNS depression can be increased when Amitriptyline is combined with Eltanolone.
Cyproheptadine The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Eltanolone.
Imipramine The risk or severity of CNS depression can be increased when Imipramine is combined with Eltanolone.
Nortriptyline The risk or severity of CNS depression can be increased when Nortriptyline is combined with Eltanolone.
Amoxapine The risk or severity of CNS depression can be increased when Amoxapine is combined with Eltanolone.
Propiomazine The risk or severity of CNS depression can be increased when Propiomazine is combined with Eltanolone.
Maprotiline The risk or severity of CNS depression can be increased when Maprotiline is combined with Eltanolone.
Doxepin The risk or severity of CNS depression can be increased when Doxepin is combined with Eltanolone.
Desipramine The risk or severity of CNS depression can be increased when Desipramine is combined with Eltanolone.
Pizotifen The risk or severity of CNS depression can be increased when Pizotifen is combined with Eltanolone.
Dosulepin The risk or severity of CNS depression can be increased when Dosulepin is combined with Eltanolone.
Zopiclone The risk or severity of adverse effects can be increased when Eltanolone is combined with Zopiclone.
Botulinum toxin type B The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Eltanolone.
Botulinum toxin type A The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Eltanolone.
Tryptophan The risk or severity of CNS depression can be increased when Tryptophan is combined with Eltanolone.
Baclofen Baclofen may increase the central nervous system depressant (CNS depressant) activities of Eltanolone.
Lorazepam The risk or severity of CNS depression can be increased when Lorazepam is combined with Eltanolone.
Ethchlorvynol The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Eltanolone.
Succinylcholine The risk or severity of CNS depression can be increased when Succinylcholine is combined with Eltanolone.
Reserpine The risk or severity of CNS depression can be increased when Reserpine is combined with Eltanolone.
Eletriptan The risk or severity of CNS depression can be increased when Eletriptan is combined with Eltanolone.
Enflurane The risk or severity of CNS depression can be increased when Enflurane is combined with Eltanolone.
Temazepam The risk or severity of CNS depression can be increased when Temazepam is combined with Eltanolone.
Reboxetine The risk or severity of CNS depression can be increased when Reboxetine is combined with Eltanolone.
Butabarbital The risk or severity of CNS depression can be increased when Butabarbital is combined with Eltanolone.
Butalbital The risk or severity of CNS depression can be increased when Butalbital is combined with Eltanolone.
Methysergide The risk or severity of CNS depression can be increased when Methysergide is combined with Eltanolone.
Cabergoline The risk or severity of CNS depression can be increased when Cabergoline is combined with Eltanolone.
Phenytoin The risk or severity of CNS depression can be increased when Phenytoin is combined with Eltanolone.
Topiramate The risk or severity of CNS depression can be increased when Topiramate is combined with Eltanolone.
Clemastine The risk or severity of CNS depression can be increased when Clemastine is combined with Eltanolone.
Venlafaxine The risk or severity of CNS depression can be increased when Venlafaxine is combined with Eltanolone.
Etomidate The risk or severity of CNS depression can be increased when Etomidate is combined with Eltanolone.
Morphine The risk or severity of CNS depression can be increased when Morphine is combined with Eltanolone.
Talbutal The risk or severity of CNS depression can be increased when Talbutal is combined with Eltanolone.
Pentobarbital The risk or severity of CNS depression can be increased when Pentobarbital is combined with Eltanolone.
Valproic acid The risk or severity of CNS depression can be increased when Valproic acid is combined with Eltanolone.
Zolmitriptan The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Eltanolone.
Codeine The risk or severity of CNS depression can be increased when Codeine is combined with Eltanolone.
Dihydroergotamine The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Eltanolone.
Tolcapone The risk or severity of CNS depression can be increased when Tolcapone is combined with Eltanolone.
Hydromorphone The risk or severity of CNS depression can be increased when Hydromorphone is combined with Eltanolone.
Olanzapine The risk or severity of CNS depression can be increased when Olanzapine is combined with Eltanolone.
Cetirizine The risk or severity of CNS depression can be increased when Cetirizine is combined with Eltanolone.
Protriptyline The risk or severity of CNS depression can be increased when Protriptyline is combined with Eltanolone.
Trimethadione The risk or severity of CNS depression can be increased when Trimethadione is combined with Eltanolone.
Clobazam The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Eltanolone.
Chlorzoxazone The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Eltanolone.
Clozapine The risk or severity of CNS depression can be increased when Clozapine is combined with Eltanolone.
Meprobamate The risk or severity of CNS depression can be increased when Meprobamate is combined with Eltanolone.
Thiethylperazine The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Eltanolone.
Palonosetron The risk or severity of CNS depression can be increased when Palonosetron is combined with Eltanolone.
Sulpiride The risk or severity of CNS depression can be increased when Sulpiride is combined with Eltanolone.
Alprazolam The risk or severity of CNS depression can be increased when Alprazolam is combined with Eltanolone.
Dexbrompheniramine The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Eltanolone.

Target Protein

Gamma-aminobutyric acid receptor subunit alpha-1 GABRA1
Gamma-aminobutyric acid receptor subunit beta-2 GABRB2
Gamma-aminobutyric acid receptor subunit gamma-2 GABRG2

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul